Business Description
Hologic Inc
NAICS : 334517
SIC : 3844
ISIN : US4364401012
Share Class Description:
HOLX: Ordinary SharesTotal Employee Number:
7,070Compare
Compare
Traded in other countries / regions
HOLX.USAHOLX.AustriaH1OL34.BrazilHO1.Germany0J5Q.UK1HOLX.ItalyHOLX.Mexico Index Membership
Russell 1000Russell 3000MSCI World IndexNASDAQ 100NASDAQ 100S&P 500 IPO Date
1990-03-01Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.94 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.48 | |||||
Debt-to-EBITDA | 2.35 | |||||
Interest Coverage | 6.94 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.24 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2 | |||||
3-Year EBITDA Growth Rate | -16.6 | |||||
3-Year EPS without NRI Growth Rate | -10.9 | |||||
3-Year FCF Growth Rate | -20.4 | |||||
3-Year Book Growth Rate | 4.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 6.9 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.19 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 84.71 | |||||
9-Day RSI | 74.66 | |||||
14-Day RSI | 68.77 | |||||
3-1 Month Momentum % | 1.04 | |||||
6-1 Month Momentum % | 11.83 | |||||
12-1 Month Momentum % | 23.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.04 | |||||
Quick Ratio | 3.32 | |||||
Cash Ratio | 2.49 | |||||
Days Inventory | 127.77 | |||||
Days Sales Outstanding | 54.31 | |||||
Days Payable | 37.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 3.4 | |||||
Shareholder Yield % | 1.57 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 51.47 | |||||
Operating Margin % | 19.21 | |||||
Net Margin % | 13.18 | |||||
EBITDA Margin % | 26 | |||||
FCF Margin % | 23.2 | |||||
OCF Margin % | 26.6 | |||||
ROE % | 11.09 | |||||
ROA % | 6.14 | |||||
ROIC % | 10.55 | |||||
3-Year ROIIC % | -1420.61 | |||||
ROC (Joel Greenblatt) % | 67.58 | |||||
ROCE % | 9.87 | |||||
Years of Profitability over Past 10-Year | 8 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 31.67 | |||||
Forward PE Ratio | 17.23 | |||||
PE Ratio without NRI | 17.76 | |||||
Shiller PE Ratio | 23.38 | |||||
Price-to-Owner-Earnings | 29.29 | |||||
PS Ratio | 4.16 | |||||
PB Ratio | 3.23 | |||||
Price-to-Tangible-Book | 16.1 | |||||
Price-to-Free-Cash-Flow | 17.93 | |||||
Price-to-Operating-Cash-Flow | 15.63 | |||||
EV-to-EBIT | 22.02 | |||||
EV-to-Forward-EBIT | 19.18 | |||||
EV-to-EBITDA | 15.96 | |||||
EV-to-Forward-EBITDA | 13.83 | |||||
EV-to-Revenue | 4.15 | |||||
EV-to-Forward-Revenue | 4 | |||||
EV-to-FCF | 17.89 | |||||
Price-to-GF-Value | 0.93 | |||||
Price-to-Projected-FCF | 1.05 | |||||
Price-to-Median-PS-Value | 1.05 | |||||
Price-to-Graham-Number | 3.57 | |||||
Earnings Yield (Greenblatt) % | 4.54 | |||||
FCF Yield % | 5.64 | |||||
Forward Rate of Return (Yacktman) % | -10.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HOLX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hologic Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4,126.5 | ||
| EPS (TTM) ($) | 2.4 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.4 | ||
| 3-Year Sortino Ratio | -0.52 | ||
| Volatility % | 13.47 | ||
| 14-Day RSI | 68.77 | ||
| 14-Day ATR ($) | 0.216451 | ||
| 20-Day SMA ($) | 75.491 | ||
| 12-1 Month Momentum % | 23.62 | ||
| 52-Week Range ($) | 51.9 - 76.07 | ||
| Shares Outstanding (Mil) | 223.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hologic Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hologic Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2026-11-18 | In 140 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-11-03 16:30 | In 126 days | ||
| Fourth quarter earnings results for 2026 | 2026-11-03 | In 125 days | ||
| Third quarter earnings conference call for 2026 | 2026-07-30 16:30 | In 30 days | ||
| Third quarter earnings results for 2026 | 2026-07-30 | In 29 days | ||
| Second quarter earnings conference call for 2026 | 2026-05-01 16:30 | 76.01 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-05-01 | 76.01 (+0.00%) | ||
| General meeting for 2026 | 2026-04-09 08:00 | 76.01 (+0.00%) | ||
| Special Meeting of Stockholders | 2026-02-05 12:00 | 74.59 (-0.11%) | ||
| First quarter earnings results for 2026 | 2026-01-29 | 75.10 (-0.12%) |
Show
Entries
Hologic Inc Frequently Asked Questions
What is Hologic Inc(HOLX)'s stock price today?
The current price of HOLX is $76.01. The 52 week high of HOLX is $76.07 and 52 week low is $51.90.
When is next earnings date of Hologic Inc(HOLX)?
The next earnings date of Hologic Inc(HOLX) is 2026-07-30 Est..
Does Hologic Inc(HOLX) pay dividends? If so, how much?
Hologic Inc(HOLX) does not pay dividend.
Guru Commentaries on NAS:HOLX
No articles.
Press Release
Articles on Hologic Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers